Latest Cost Control News

Aurelia Metals has successfully met its FY25 production and cost guidance, driven by a strong ramp-up at Federation Mine and the start of development at Great Cobar. The company’s solid quarterly performance underpins its growth ambitions for FY26.

Hillgrove Resources reported operational gains and exploration success in Q2 2025, despite lower copper output due to grade variability. The Nugent acceleration project is progressing ahead of schedule, setting the stage for increased throughput and cost efficiencies in 2026.

Yancoal’s June quarter report reveals steady coal production despite weather disruptions and a dip in realised prices, supported by a robust $1.8 billion cash reserve. The company remains confident in hitting upper-end production guidance amid ongoing market volatility.

Vinyl Group Ltd reports a 17% quarterly increase in cash receipts to $3.786 million, driven by acquisitions and platform growth, while targeting cash-flow breakeven by Q2 FY26 through operational efficiencies and margin improvements.

29Metals Limited reported a stronger June quarter with increased copper production at Golden Grove, offset by higher costs and deferred capital spending on the Gossan Valley project. The company also secured a final $54 million insurance payout and improved liquidity despite ongoing operational challenges at Capricorn Copper.

Kula Gold Limited has reported impressive high-grade gold drilling results at its Mt Palmer Gold Mine, completing an 80% JV earn-in, while progressing exploration at Kirup and securing a niobium project approval in Malawi. The company faces a tight cash position but is actively managing funding.

Rio Tinto reports a robust 13% year-on-year increase in copper equivalent production for Q2 2025, alongside record bauxite output and progress on key projects like Simandou and Oyu Tolgoi. The company maintains its 2025 guidance, signaling confidence in its diversified growth strategy.

Cromwell Property Group has provided fresh details on its Barton development, confirming a $201 million total cost and a projected yield exceeding 6.3%. This update clarifies financial expectations amid growing market interest.

Neurizon Therapeutics has received positive feedback from the FDA on its plan to resolve the clinical hold on its ALS drug candidate NUZ-001, with key preclinical studies completed ahead of schedule. The company aims to resume clinical trials in late 2025.

Arrow Minerals has completed key scoping studies for its Niagara Bauxite and Simandou North Iron projects but has halted operations in Guinea due to unclear exploration permit status.

Capricorn Metals capped FY25 with a strong Q4 at Karlawinda, delivering gold production at the upper guidance range while pushing forward major development milestones.

OMG Group Limited has reported record monthly sales of $602,000 in June 2025, driven by surging ecommerce demand and strong operational cashflow, positioning the company for continued growth in FY26.